M
Mathias Rauchhaus
Researcher at Charité
Publications - 101
Citations - 9478
Mathias Rauchhaus is an academic researcher from Charité. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 39, co-authored 101 publications receiving 8683 citations. Previous affiliations of Mathias Rauchhaus include Martin Luther University of Halle-Wittenberg & University of Rostock.
Papers
More filters
Journal ArticleDOI
Endotoxin and immune activation in chronic heart failure: a prospective cohort study.
Josef Niebauer,Hans-Dieter Volk,Michael Kemp,Martin Dominguez,Ralf R. Schumann,Mathias Rauchhaus,Philip A. Poole-Wilson,Andrew J.S. Coats,Stefan D. Anker,Stefan D. Anker +9 more
TL;DR: Raised concentrations of endotoxin and cytokines are found in patients with chronic heart failure during acute oedematous exacerbation and the preliminary findings suggest that endotoxin may trigger immune activation in patientsWith chronic heart fail, intensified diuretic treatment can normalise endotoxin concentrations.
Journal ArticleDOI
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Mathias Rauchhaus,Wolfram Doehner,Darrel P. Francis,Constantinos H. Davos,Michael Kemp,Christa Liebenthal,Josef Niebauer,James Hooper,Hans-Dieter Volk,Andrew J.S. Coats,Stefan D. Anker +10 more
TL;DR: Assessment of sT NF-R1 may be useful in identifying patients who are at high risk of death and in monitoring patients undergoing anti-TNF-alpha treatment, independent of established markers of CHF severity.
Journal ArticleDOI
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).
Aldo P. Maggioni,Ulf Dahlström,Gerasimos Filippatos,Ovidiu Chioncel,Marisa Crespo Leiro,Jarosław Drożdż,Friedrich Fruhwald,Lars Gullestad,Damien Logeart,Gianna Fabbri,Renato Urso,Marco Metra,John Parissis,Hans Persson,Piotr Ponikowski,Mathias Rauchhaus,Adriaan A. Voors,Olav W. Nielsen,Faiez Zannad,Faiez Zannad,Luigi Tavazzi +20 more
TL;DR: The ESC‐HF Pilot survey was aimed to describe clinical epidemiology and 1‐year outcomes of outpatients and inpatients with heart failure and validating structure, performance, and quality of the data set for continuing the survey into a permanent Registry.
Journal ArticleDOI
Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging
Stefan D. Anker,Wolfram Doehner,Mathias Rauchhaus,Rakesh Sharma,Darrel P. Francis,Christoph Knosalla,Constantinos H. Davos,Mariantonietta Cicoira,Waqar Shamim,Michel Kemp,Robert Segal,Karl Josef Osterziel,Francisco Leyva,Roland Hetzer,Piotr Ponikowski,Andrew J.S. Coats +15 more
TL;DR: High serum UA levels are a strong, independent marker of impaired prognosis in patients with moderate to severe CHF and the relationship between serum UA and survival in CHF is graded.
Journal ArticleDOI
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure Results From 2 Placebo-Controlled Studies
Wolfram Doehner,Nina Schoene,Mathias Rauchhaus,Francisco Leyva-Leon,Darrell V. Pavitt,DA Reaveley,Gerhard Schuler,Andrew J.S. Coats,Stefan D. Anker,Rainer Hambrecht +9 more
TL;DR: In hyperuricemic CHF patients, XO inhibition with allopurinol improves peripheral vasodilator capacity and blood flow both locally and systemically.